Subchronic treatment with St John's wort produces a positive shift in emotional processing in healthy volunteers

被引:6
|
作者
Warren, Matthew B. [1 ]
Cowen, Philip J. [1 ,2 ]
Harmer, Catherine J. [1 ,2 ]
机构
[1] Univ Oxford, Dept Psychiat, Oxford, England
[2] Univ Oxford, Warneford Hosp, Oxford Hlth NHS Fdn Trust, Oxford, England
关键词
St John's wort; hypericum; depression; emotional processing; TERM ANTIDEPRESSANT TREATMENT; HYPERICUM-PERFORATUM; DOUBLE-BLIND; MAJOR DEPRESSION; ATTENTIONAL BIAS; EXTRACT; PLACEBO; MEMORY; RECOGNITION; EXPRESSION;
D O I
10.1177/0269881118812101
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The neurocognitive model of antidepressant treatment in depression states that antidepressants work by producing relatively immediate positive shifts in emotional processing, which translate into clinical improvement with time. St John's Wort has shown antidepressant potential in randomised controlled trials; however, its pharmacological actions are broad and it is unknown whether treatment also produces changes in emotional processing. Aims: We investigated whether short-term treatment with St John's wort has similar effects on emotional processing to those reported with other antidepressants such as selective serotonergic reuptake inhibitors. Methods: Forty-eight healthy participants were given St John's wort or placebo treatment for seven days. On day 7 they completed a battery of tasks to measure emotional processing and other elements of cognition. Results: St John's wort treatment produced similar changes to other antidepressants, for example reducing recognition of disgusted faces and attention to fearful faces, while increasing memory for positive words. We failed to find evidence for an effect of St John's wort on other aspects of cognition including working memory. Conclusions: These findings lend support to the theory that the production of early positive biases in emotional processing may be a common feature of all clinically effective antidepressants with diverse pharmacological mechanisms.
引用
收藏
页码:194 / 201
页数:8
相关论文
共 50 条
  • [31] No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract
    Arold, G
    Donath, F
    Maurer, A
    Diefenbach, K
    Bauer, S
    Henneicke-von Zepelin, HH
    Friede, M
    Roots, I
    PLANTA MEDICA, 2005, 71 (04) : 331 - 337
  • [32] St. John's wort treatment in women bears risks beyond pharmacokinetic drug interactions
    Hohmann, Nicolas
    Maus, Anna
    Carls, Alexandra
    Haefeli, Walter E.
    Mikus, Gerd
    ARCHIVES OF TOXICOLOGY, 2016, 90 (04) : 1013 - 1015
  • [33] Effects of st John's Wort (Hypericum perforatum L.) extract on plasma androgen concentrations in healthy men and women:: A pilot study
    Donovan, JL
    DeVane, CL
    Lewis, JG
    Wang, JS
    Ruan, Y
    Chavin, KD
    Markowitz, JS
    PHYTOTHERAPY RESEARCH, 2005, 19 (10) : 901 - 906
  • [34] Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients
    Bauer, S
    Störmer, E
    Johne, A
    Krüger, H
    Budde, K
    Neumayer, HH
    Roots, I
    Mai, I
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (02) : 203 - 211
  • [35] Efficacy of St. John's wort extract WS® 5570 in acute treatment of mild depression
    Kasper, S.
    Gastpar, M.
    Muller, W. E.
    Volz, H. P.
    Dienel, A.
    Kieser, M.
    Moeller, H. J.
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 258 (01) : 59 - 63
  • [36] Effects of treatment with a commercially available St John's Wort product (Movina®) on cholesterol levels in patients with hypercholesterolemia treated with simvastatin
    Eggertsen, Robert
    Andreasson, Ake
    Andren, Lennart
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2007, 25 (03) : 154 - 159
  • [37] The effect of St. John's wort on the pharmacokinetics, metabolism and biliary excretion of finasteride and its metabolites in healthy men
    Lundahl, Anna
    Hedeland, Mikael
    Bondesson, Ulf
    Knutson, Lars
    Lennernas, Hans
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 36 (4-5) : 433 - 443
  • [38] St. John's wort (hypericum perforatum) as a treatment for premenstrual dysphoric disorder: Case report
    Huang, KL
    Tsai, SJ
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2003, 33 (03): : 295 - 297
  • [39] St. John’s wort treatment in women bears risks beyond pharmacokinetic drug interactions
    Nicolas Hohmann
    Anna Maus
    Alexandra Carls
    Walter E. Haefeli
    Gerd Mikus
    Archives of Toxicology, 2016, 90 : 1013 - 1015
  • [40] Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients
    Mai, I
    Störmer, E
    Bauer, S
    Krüger, H
    Budde, K
    Roots, I
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (04) : 819 - 822